Ypsomed Holding AG (XSWX:YPSN) Shares Outstanding (EOP): 13.1 Mil (As of Mar. 2026)


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
92 GF Score
Price CHF360.60
GF Value CHF397.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Shares Outstanding (EOP)?

Ypsomed Holding AG XSWX:YPSN -0.66% 92 Shares Outstanding (EOP) is 13.1 Mil as of Mar. 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF397.15 (Fairly Valued). The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Ypsomed Holding AG's shares outstanding for the quarter that ended in Mar. 2026 was 13.1 Mil.

Ypsomed Holding AG's quarterly shares outstanding stayed the same from Sep. 2025 (13.1 Mil) to Mar. 2026 (13.1 Mil).

Ypsomed Holding AG's annual shares outstanding declined from Mar. 2025 (13.6 Mil) to Mar. 2026 (13.1 Mil). It means Ypsomed Holding AG bought back shares from Mar. 2025 to Mar. 2026 .


Ypsomed Holding AG  (XSWX:YPSN) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Ypsomed Holding AG Shares Outstanding (EOP) Related Terms


Ypsomed Holding AG Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG Shares Outstanding (EOP) Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.69 13.65 13.65 13.65 13.15

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.65 13.65 13.65 13.15 13.15

XSWX:YPSN vs ISRG, BDX, MDLN: Shares Outstanding (EOP) Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Shares Outstanding (EOP) falls into.


XSWX:YPSN
92GF Score
Ypsomed Holding AG XSWX:YPSN
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 13.1 Mil mean?
Ypsomed Holding AG (XSWX:YPSN) has a Shares Outstanding (EOP) of 13.1 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Ypsomed Holding AG and its competitors.
Is Ypsomed Holding AG's Shares Outstanding (EOP) too high?
Ypsomed Holding AG's current Shares Outstanding (EOP) is 13.1 Mil. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Shares Outstanding (EOP) compare to ISRG and BDX?
Ypsomed Holding AG's Shares Outstanding (EOP) of 13.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current Shares Outstanding (EOP) is 13.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF397.15, compared to a current price of CHF360.60 — trading 9.2% below its estimated fair value. The current Shares Outstanding (EOP) is 13.1 Mil. Ypsomed Holding AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Shares Outstanding (EOP) is 13.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF360.60 is trading 9.2% below its estimated GF Value™ of CHF397.15. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for XSWX:YPSN:

  • Shares Outstanding (EOP): 13.1 Mil
  • GF Value™: CHF397.15 vs. price of CHF360.60 (9.2% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score

Get the complete analysis for XSWX:YPSN

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF360.60
Price
CHF397.15
GF Value